0001628280-19-011197.txt : 20190826 0001628280-19-011197.hdr.sgml : 20190826 20190826194528 ACCESSION NUMBER: 0001628280-19-011197 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190822 FILED AS OF DATE: 20190826 DATE AS OF CHANGE: 20190826 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Talasaz AmirAli CENTRAL INDEX KEY: 0001753159 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 191054089 MAIL ADDRESS: STREET 1: 18 ISABELLA AVENUE CITY: ATHERTON STATE: CA ZIP: 94027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 505 PENOBSCOT DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 wf-form4_156686310595612.xml FORM 4 X0306 4 2019-08-22 0 0001576280 Guardant Health, Inc. GH 0001753159 Talasaz AmirAli 505 PENOBSCOT DRIVE REDWOOD CITY CA 94063 1 1 0 0 Chairman, President and COO COMMON STOCK 2019-08-23 4 S 0 1596 98.78 D 1965 D COMMON STOCK 2019-08-23 4 S 0 462 99.24 D 1503 D COMMON STOCK 2019-08-23 4 S 0 6281 94.79 D 3635507 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-08-23 4 S 0 6561 95.53 D 3628946 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-08-23 4 S 0 3103 96.76 D 3625843 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-08-23 4 S 0 3328 97.72 D 3622515 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-08-23 4 S 0 4489 98.78 D 3618026 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-08-23 4 S 0 1294 99.24 D 3616732 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-08-23 4 S 0 170 94.80 D 10385 I Shares held by Samar Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-08-23 4 S 0 177 95.52 D 10208 I Shares held by Samar Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-08-23 4 S 0 81 96.80 D 10127 I Shares held by Samar Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-08-23 4 S 0 91 97.71 D 10036 I Shares held by Samar Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-08-23 4 S 0 125 98.77 D 9911 I Shares held by Samar Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-08-23 4 S 0 31 99.24 D 9880 I Shares held by Samar Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-08-23 4 S 0 170 94.80 D 10386 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-08-23 4 S 0 177 95.52 D 10209 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-08-23 4 S 0 82 96.80 D 10127 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-08-23 4 S 0 91 97.71 D 10036 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-08-23 4 S 0 125 98.77 D 9911 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-08-23 4 S 0 31 99.24 D 9880 I Shares held by Sana Talasaz 2018 Irrevocable Trust COMMON STOCK 2019-08-26 4 M 0 4721 4.18 A 6224 D COMMON STOCK 2019-08-26 4 S 0 1267 92.26 D 4957 D COMMON STOCK 2019-08-26 4 S 0 1714 93.12 D 3243 D COMMON STOCK 2019-08-26 4 S 0 1288 94.14 D 1955 D COMMON STOCK 2019-08-26 4 S 0 501 94.87 D 1454 D COMMON STOCK 2019-08-26 4 S 0 3553 92.26 D 3613179 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-08-26 4 S 0 4767 93.12 D 3608412 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-08-26 4 S 0 3613 94.14 D 3604799 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-08-26 4 S 0 1403 94.87 D 3603396 I Shares held by Talasaz and Eskandari 2017 Family Trust COMMON STOCK 2019-08-26 4 S 0 96 92.27 D 9784 I Shares held by Samar Talasaz 2018 Irrevocable Trust STOCK OPTION (RIGHT TO BUY) 4.18 2019-08-26 4 M 0 4721 0 D 2022-07-13 COMMON STOCK 4721.0 1081850 D These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Some of the shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.17 to $99.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.17 to $99.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.12 to $95.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.12 to $96.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.15 to $97.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.16 to $98.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.60 to $92.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.60 to $93.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.60 to $94.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.60 to $95.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017. This Form 4 is the second of three filed. /s/ Michael Wiley, as Attorney-in-Fact for AmirAli Talasaz 2019-08-26